Cargando…
Growth Factor Therapy for Parkinson’s Disease: Alternative Delivery Systems
Despite decades of research and billions in global investment, there remains no preventative or curative treatment for any neurodegenerative condition, including Parkinson’s disease (PD). Arguably, the most promising approach for neuroprotection and neurorestoration in PD is using growth factors whi...
Autores principales: | Jarrin, Sarah, Hakami, Abrar, Newland, Ben, Dowd, Eilís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543245/ https://www.ncbi.nlm.nih.gov/pubmed/33896851 http://dx.doi.org/10.3233/JPD-212662 |
Ejemplares similares
-
Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
por: Kelly, Rachel, et al.
Publicado: (2020) -
Brain repair for Parkinson’s disease: is the answer in the matrix?
por: Moriarty, Niamh, et al.
Publicado: (2018) -
A role for viral infections in Parkinson’s etiology?
por: Olsen, Laura K., et al.
Publicado: (2018) -
Back to the future: lessons from past viral infections and the link with Parkinson’s disease
por: Dowd, Eilis, et al.
Publicado: (2021) -
Anti-inflammatory cytokine-eluting collagen hydrogel reduces the host immune response to dopaminergic cell transplants in a rat model of Parkinson’s disease
por: Cabré, Sílvia, et al.
Publicado: (2021)